P. Quaglino

From north to south: exploring Italian sun-exposure habits through the "Save your skin" campaign.
20250 citationsauthor #29
Italian S3-Guideline on the treatment of atopic eczema - First Update, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA).
20240 citationsauthor #9
Follicular colonization in melanocytic nevi and melanoma: A literature review
20232 citationsauthor #5
Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study
20220 citationsauthor #10
CD27 mRNA expression in mycosis fungoides.
20210 citationsauthor #6
HERV-E expression in peripheral mononuclear cells of patient with Psoriasis.
20214 citationsauthor #4
Nutritional Interventions for Patients with Melanoma: From Prevention to Therapy—An Update
202115 citationsauthor #7
The evolving field of Dermato‐oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV–UEMS and EORTC Cutaneous Lymphoma Task Force
202027 citationsauthor #30
Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients
202058 citationsauthor #10
Expression of miRNA 155, FOXP3 and ROR gamma, in children with moderate and severe atopic dermatitis.
202016 citationsauthor #6
Lack of detection of cutavirus DNA using PCR real time in Cutaneous T-cell Lymphomas (CTCL).
201810 citationsauthor #7
Co-isolation and analysis of extracellular vesicle (EV)-associated DNA and cell free DNA (cfDNA) to improve the diagnostic and prognostic value of circulating BRAF V600E in metastatic melanoma patients.
20180 citationsauthor #7
Is HERV-K and HERV-W expression regulated by mir-155 in Sézary syndrome?
20181 citationsauthor #7
DNA from Human Polyomaviruses, MWPyV, HPyV6, HPyV7, HPyV9 and HPyV12 in Cutaneous T-cell Lymphomas
201811 citationsauthor #8
Contents Vol. 232, 2016
20170 citationsauthor #12
Dermoscopic diagnosis of amelanotic/hypomelanotic melanoma
201737 citationsauthor #13
miR‐155 expression in Primary Cutaneous T‐Cell Lymphomas (CTCL)
201720 citationsauthor #10
Acknowledgement to Referees for Dermatology 2016
20170 citationsauthor #12
miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
201642 citationsauthor #10
PCR Real time Mismatch Amplification Mutation Assay (MAMA Real Time PCR) for evaluation of TNF-α promoter gene polymorphism -308 G/A in patients with psoriasis.
20162 citationsauthor #8
Tumor Suppressors miR-146 a Exerts Differential Effects on Melanoma Growth and Metastatization
20160 citationsauthor #10
Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas
201518 citationsauthor #10
Spiky follicular mycosis fungoides: a clinicopathologic study of 8 cases
201533 citationsauthor #8
Blood flow cytometry in Sézary syndrome: new insights on prognostic relevance and immunophenotypic changes during follow-up.
201548 citationsauthor #10
Evaluation of PMNs functional and phenotypical alterations in mycosis fungoides patients.
20140 citationsauthor #11
ILDS Newsletter No. 33
20140 citationsauthor #45
Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: overview of the literature and clinical experience with long-term follow-up data
20130 citationsauthor #1
Abstracts of the 8th World Congress of Melanoma, the 9th Congress of the European Association of Dermatology (EADO), the 7th Interdisciplinary Melanoma/Skin Cancer Meeting, and the 3rd European Post-Chicago Melanoma Meeting. July 17-20, 2013. Hamburg, Germany.
20131 citationsauthor #44
Guidelines on the use of extracorporeal photopheresis
2013218 citationsauthor #8
Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T‐cell lymphoma: a single center clinical experience with long‐term follow‐up data and a brief overview of the literature
201349 citationsauthor #1
ILDS Newsletter No. 27
20130 citationsauthor #45
Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients.
20136 citationsauthor #1
Phenotype instability in Sézary cells: follow-up results in 107 patients
20130 citationsauthor #8
Overall Survival, Disease Free Survival and Survival after Recurrence across gender in melanoma patients: what has changed?
20120 citationsauthor #2
Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients
201238 citationsauthor #1
Electrochemotherapy with intravenous Bleomycin in the treatment of cutaneous. Metastases: a prospettive single center experience with long term follow-up data
20120 citationsauthor #2
Moderate to severe psoriasis: clinico-pathologic and immunologic correlations
20120 citationsauthor #1
Contents Vol. 224, 2012
20120 citationsauthor #93
Functional and phenotypical alterations of polymorphonuclear cells in atopic dermatitis patients
20120 citationsauthor #9
Newsletter No. 25
20120 citationsauthor #93
Recurrence in patients with melanoma of the trunk is influenced by the type of drainage in different lymphatic basins
20120 citationsauthor #2
Dermoscopy and Digital Dermoscopy Analysis of Palmoplantar ‘Equivocal’ Pigmented Skin Lesions in Caucasians
201211 citationsauthor #8
FOXP3 AND MELANOMA: THE BIG ESCAPE?
20120 citationsauthor #1
Functional and Phenotypical Impairment of Polymorphonuclear Cells in Atopic Dermatitis: An Additional Cause for the Known Susceptibility to Infections?
20129 citationsauthor #9
Endothelial and Smooth muscle cell Derived Neuropin-like molecule and AP-2 family protein expression in primary melanoma predicts Disease Free Survival in melanoma patients
20120 citationsauthor #3
miR214 expression and interconnected endothelial and smooth muscle cell derived neutropilin-like molecule ESDN and AP-2 family protein expression in primary melanoma
20120 citationsauthor #4
Regulatory T cells and T helper 17 cells in the pathogenesis of dermatitis herpetiformis
20120 citationsauthor #2
Expression of AP-2α, AP-2γ and ESDN in primary melanomas: correlation with histopathological features and potential prognostic value.
201215 citationsauthor #3
Adult-onset cutaneous mastocytosis in monozygotic twins.
20111 citationsauthor #1
FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy
201133 citationsauthor #1
Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients.
20119 citationsauthor #10
ILDS Newsletter No. 20
20110 citationsauthor #49
Th1, Th2, Th17 and Regulatory T Cell Pattern in Psoriatic Patients: Modulation of Cytokines and Gene Targets Induced by Etanercept Treatment and Correlation with Clinical Response
201190 citationsauthor #1
Extracorporeal photopheresis in the treatment of erythrodermic cutaneous T-cell lymphoma: combination therapy results and long-term follow-up.
20100 citationsauthor #1
Treatment of Sézary Syndrome by anti-CD52 monoclonal antibodt Alemtuzumab: clinical and immunological findings in 24 patients
20101 citationsauthor #2
Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp.
201018 citationsauthor #5
Long term results of electrochemotherapy
20100 citationsauthor #1
TCRgamma-chain gene rearrangement by GeneScan: incidence and significance of clonal heterogeneity in Sézary syndrome.
201017 citationsauthor #9
High‐dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha‐Habermann disease
201015 citationsauthor #4
Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre
201051 citationsauthor #6
THERAPEUTIC HOTLINE: A rare vandetanib‐induced photo‐allergic drug eruption
201019 citationsauthor #2
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study.
2010179 citationsauthor #1
Clonal heterogeneity in mycosis fungoides/Sézary Syndrome: incidence, relation with clinico-pathologic features and prognostic significance
20100 citationsauthor #6
Cutaneous melanoma metastases arising on a split-skin graft donor site.
200912 citationsauthor #4
Phenotypical and functional alterations of polymorphonucleates in sezary syndrome patients
20090 citationsauthor #2
Zosteriform Cutaneous Metastases: A Literature Meta‐Analysis and a Clinical Report of Three Melanoma Cases
200959 citationsauthor #4
Newsletter No. 8/2009
20090 citationsauthor #39
Reciprocal Modulation of Circulating CD4+CD25+bright T Cells Induced by Extracorporeal Photochemotherapy in Cutaneous T-Cell Lymphoma and Chronic GRAFT- Versus-Host-Disease Patients
200922 citationsauthor #1
9330 Electrochemotherapy with intravenous bleomycin in the treatment of cutaneous and subcutaneous metastases: results of a prospective single centre trial
20090 citationsauthor #1
Skin metastases of malignant melanoma: a clinical and prognostic survey
200965 citationsauthor #5
Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood.
200939 citationsauthor #5
Therapeutic approaches in advanced mycosis fungoides and Sezary Sindrome. A 30-year single institution experience
20090 citationsauthor #1
Herpesviridae e parvoviridae DNA expression in CTCL: pathogenetic and prognostic role
20080 citationsauthor #3
Electrochemotherapy with intravenous bleomycin: an additional therapeutic procedure in the local treatment of relapsed/refractory skin melanoma metastases
20080 citationsauthor #1
Flow cytometry immunophenotyping in mycosis fungoides.
20087 citationsauthor #3
TCRc-Chain Gene Rearrangement by PCR-Based GeneScan: Diagnostic Accuracy Improvement and Clonal Heterogeneity Analysis in Multiple Cutaneous
20081 citationsauthor #3
Low-dose intermittent Alemtuzumab in Sézary Syndrome: clinical activity, toxicity profile and immunological findings in 17 patients.
20080 citationsauthor #2
Heterogeneity of Circulating CD4+ Memory T-Cell Subsets in Erythrodermic Patients: CD27 Analysis Can Help to Distinguish Cutaneous T-Cell Lymphomas from Inflammatory Erythroderma
200827 citationsauthor #3
Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T‐cell lymphomas and healthy subjects: lack of a pathogenic role
200826 citationsauthor #4
TCRgamma-chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples.
200874 citationsauthor #3
PAS expression is related to survival in Sézary syndrome patients
20080 citationsauthor #3
Flow cytometry immunophenotyping in mycosis fungoides. Authors' reply
20080 citationsauthor #3
Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients
200732 citationsauthor #1
Melanoma and pregnancy: a 30-year experience at the Turin Melanoma Centre and a review of the literature data
20072 citationsauthor #4
Subject Index Vol. 214, 2007
20070 citationsauthor #52
Primary cutaneous T cell lymphomas: HHV7 involvement investigated by real time quantitative PCR and comparison with healthy subjects.
20070 citationsauthor #4
Contents Vol. 214, 2007
20070 citationsauthor #51
What is the role of sequential reverse-transcriptase polymerase chain reaction analysis of melanoma-specific mRNA in the peripheral blood of melanoma patients?
20076 citationsauthor #1
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients.
2007183 citationsauthor #2
Primary cutaneous B-cell lymphoma - Reply
20061 citationsauthor #2
Acknowledgement to Referees for Dermatology 2006
20060 citationsauthor #3
Expression Pattern of Chemokine Receptors and Chemokine Release in Inflammatory Erythroderma and Sézary Syndrome
200634 citationsauthor #3
Primary cutaneous B-cell lymphoma. Authors' reply
20060 citationsauthor #4
Contents Vol. 213, 2006
20060 citationsauthor #3
Sequential peripheral blood tyrosinase expression is an independent time-related prognostic parameter in Stage III and IV metastatic melanoma patients: A clinical follow-up study of 310 patients at a single institution.
20060 citationsauthor #1
Sclero-atrophic mycosis fungoides with a cytotoxic atypical phenotype
20060 citationsauthor #2
Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study.
200619 citationsauthor #3
Subject Index Vol. 213, 2006
20060 citationsauthor #3
T‐cell receptor γ gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T‐cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings
2005119 citationsauthor #2
Time course and pattern of first relapse in stage I-II primary cutaneous melanoma: a multivariate analysis of disease-free survival in 3,174 patients followed-up at the Turin Melanoma Centre from 1975 to 2004.
200514 citationsauthor #2

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT